Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
19.64 USD | -0.38% | +1.44% | -11.94% |
09/05 | UBS Adjusts Price Target on Premier to $21 From $22, Maintains Neutral Rating | MT |
08/05 | Baird Adjusts Price Target on Premier to $22 From $25, Keeps Neutral Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.94% | 206.6Cr | |
-5.00% | 18TCr | |
+2.38% | 11TCr | |
-2.29% | 6.85TCr | |
+1.16% | 4.97TCr | |
+8.07% | 4.45TCr | |
+2.33% | 4.07TCr | |
+22.16% | 3.12TCr | |
+1.97% | 2.61TCr | |
+15.30% | 2.53TCr |
- Stock Market
- Equities
- PINC Stock
- News Premier, Inc.
- Nephron Research Adjusts Premier's Price Target to $28 From $31, Keeps Hold Rating